‘Social smokers’ are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress. 
The study also shows that the risk of lung cancer death for ‘social smokers’ – those who smoke less than ten cigarettes per day – is not substantially lower than those who smoke more than 20 cigarettes a day.
Researchers say their study suggests that cutting down, or combining fewer cigarettes with vaping, is no substitute for quitting.
The research was by Dr Pallavi Balte and Dr Elizabeth Oelsner at Columbia University Irving Medical Center, New York, USA. Dr Balte told the virtual conference: “Everyone knows that smoking is bad for you, but it’s easy to assume that if you only smoke a little, the risks won’t be too high.
“Previous research suggests that people are cutting down on smoking, for example in the USA the proportion of smokers smoking less than ten cigarettes per day has increased from 16% to 27%. So, we wanted to study the risks to social smokers compared to people who don’t smoke and compared to heavier smokers.”
The study included 18,730 people selected from a multi-ethnic sample of the general US population with an average age of 61. Researchers followed the people for an average of 17 years, during which time 649 died of respiratory disease and 560 died of lung cancer.
Among non-smokers, the proportion of people who died from respiratory diseases was 1.8% and the proportion who died of lung cancer was 0.6%. Among social smokers (people who smoked less than ten cigarettes a day), around 3.3% died from respiratory diseases and 4.7% died from lung cancer. For heavy smokers (people who smoked more than 20 cigarettes a day), these proportions were 10.1% and 12.9%, respectively.
The researchers calculated the death rates from respiratory disease and lung cancer and compared these rates between non-smokers, social smokers and heavy smokers. They took account of other factors that can influence death rates, such as age, sex, race, educational attainment, and body weight.
They found that social smokers were 2.5 times as likely to die of respiratory disease and 8.6 times as likely to die of lung cancer, compared to non-smokers. Social smokers had around half the rate of death from respiratory disease as heavy smokers, but their rate of lung cancer death was two thirds that of heavy smokers.
Dr Balte added: “You might think that if you only smoke a few cigarettes a day you are avoiding most of the risk. But our findings suggesting that social smoking is disproportionately harmful.
“Smoking is dangerous, regardless of whether you are a heavy smoker or a social smoker, so if you don’t want to die of lung cancer or respiratory disease, the best action is to quit completely.”
Dr Balte and her colleagues continue to study the effects of social smoking as well as investigating the effects of new habits such as vaping.
Jørgen Vestbo, who was not involved in the research, is Chair of the European Respiratory Advocacy Council and Professor of Respiratory Medicine at the University of Manchester, UK. He said: “Although the proportion of people who smoke habitually is falling in many countries, we should still be concerned about those who identify as social smokers. Cutting down on smoking is a step in the right direction, as quitting tobacco is one of the best ways to protect the lungs and our overall health, but it’s clear that there is no safe level of smoking.
“This large study is important because it shows that smoking less will probably not have the effect that people are hoping for. We need to do all we can to support smokers to quit completely using evidence-based means, for example with access to support services, and nicotine patches or gum.”
Notes to editors
 Abstract no: OA4389, “Association of low-intensity smoking with respiratory and lung cancer mortality”, by Pallavi Balte et al; “From tobacco and vaping health effects to tobacco cessation” session, 10:40 – 11:40 hrs CEST, Tuesday 8 September:
Funding: This work was funded by the US National Institutes of Health / National Heart, Lung, and Blood Institute.
The European Respiratory Society (ERS) International Congress is the once-a-year occasion when the world’s respiratory experts meet to present and discuss the latest research on topics such as asthma, COPD, lung cancer, pollution and smoking. Due to coronavirus, the Congress is going virtual for the first time ever, with over 25,000 participants from all over the world taking part in the exchange of scientific and clinical excellence across the entire field of respiratory medicine. The reputation of ERS derives from the outstanding scientific programme of its International Congress, which is now the largest respiratory meeting in the world. https://erscongress.org